Answer
The safety and efficacy of Xeplion (paliperidone palmitate) have not been established in children and adolescents under 18 years, and no data are available.
Sources for this answer
- XEPLION 150 mg prolonged release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked